All News Zhuhai Rundu Pharmaceutical Co., Ltd.

Equities

002923

CNE1000033G8

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
9.42 ^CNY	+3.18%		+1.73%	-23.66%

Jul. 02	Zhuhai Rundu Pharmaceutical Gets Nod for Valsartan Hydrochlorothiazide Tablets	MT
Jun. 17	Rundu Pharmaceutical Probes Allegations of Toxic Food Production	MT

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zhuhai Rundu Pharmaceutical Gets Nod for Valsartan Hydrochlorothiazide Tablets	Jul. 02	MT
Rundu Pharmaceutical Probes Allegations of Toxic Food Production	Jun. 17	MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024	May. 20	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Rundu Pharmaceutical's Rabeprazole Sodium Tablets Chosen for China's Centralized Procurement	Nov. 09	MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Zhuhai Rundu Pharma Gets Supplementary Application Approval For Hypertension Drug	23-07-26	MT
Rundu Pharmaceutical Gets Nod to Market Raw Drug Material	23-07-13	MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2022, Payable on 31 May 2023	23-05-19	CI
Tianyu Pharmaceutical Unit Gets Approval to Market Hypertension Drug in China	23-05-09	MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-04-27	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Management Appointments	23-03-15	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Rundu Pharmaceutical Unit Wins Drug Production License	22-10-04	MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-12	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Proposes Cash Dividend for 2021	22-04-20	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Zhuhai Rundu Pharmaceutical Co., Ltd.

Equities

002923

CNE1000033G8

All News

Filters